Allegro Diagnostics
Development of genomic tests to support the diagnosis and management of lung cancer.
Employees
Enterprise value
$22—32m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
N/A | Acquisition | ||
| Total Funding | 000k | ||
Catalyst Health Ventures(exited)
Kodiak Venture Partners(exited)
Catalyst Health Ventures(exited)
National Cancer Institute (NCI)(exited)
Boston University(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.